⏳ Fetching live dividend data...
Home › Calculator › CUTR Dividend Calculator 2026
Cutera, Inc. · NASDAQ
Price: $0.10 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CUTR → $17517448026226.36M in 10 years · $1,434,455,585,591,395,300.00/month
Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide. The company's comprehensive product line includes several advanced devices: Secret PRO, an innovative system combining fractional CO2 technology for thorough skin resurfacing with radio frequency (RF) microneedling for deep dermal tissue restructuring. truSculpt flex, a bio-electrical muscle stimulation apparatus engineered to support individuals across all fitness capabilities. excel V+, a versatile platform designed for addressing vascular and benign pigmented lesions. truSculpt iD, specifically tailored for the non-invasive body contouring sector. Secret RF, a fractional RF microneedling system that promotes precise tissue coagulation and hemostasis. Cutera also provides robust multi-application platforms: The enlighten platform, a laser system highly effective for tattoo removal, as well as treating benign pigmented lesions and acne scarring. The excel HR platform, offering an extensive hair removal solution compatible with diverse skin types. The xeo platform, a adaptable system where users can acquire various handpiece attachments to manage unwanted hair, treat vascular lesions, and achieve overall skin revitalization by targeting discoloration, fine lines, and laxity. In addition to its device offerings, Cutera distributes a range of skincare products and delivers post-warranty support, accessible via extended service agreements or direct billing. The company supplies specialized pulsed light handpieces for treating discoloration, facilitating hair removal, and managing vascular conditions. It further offers Pearl and Pearl Fractional handpieces, along with essential consumables such as handpiece refills, cycle refills, consumable tips, and marketing materials, all available for purchase through its official website. Cutera's products are marketed and sold through a direct sales team, reaching a wide spectrum of medical and aesthetic professionals. This includes plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, other certified practitioners, and even medical doctors performing aesthetic procedures in non-clinical environments. Founded in 1988, Cutera, Inc. maintains its corporate headquarters in Brisbane, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CUTR position with:
Real after-tax yield depends on where you live and how you hold CUTR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2063.98% | 2061.18% | $206,398 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1754.38% | 1751.58% | $175,438 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1651.18% | 1648.38% | $165,118 / yr |
| 🇬🇧 UK ISA | 0% | 2063.98% | 2061.18% | $206,398 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1883.38% | 1880.58% | $188,338 / yr |
| 🇨🇦 TFSA | 0% | 2063.98% | 2061.18% | $206,398 / yr |
| 🇨🇦 CA Taxable | 25% | 1547.99% | 1545.19% | $154,799 / yr |
| 🇦🇺 Super (pension) | 15% | 1754.38% | 1751.58% | $175,438 / yr |
| 🇦🇺 AU Taxable | 30% | 1444.79% | 1441.99% | $144,479 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1519.61% | 1516.81% | $151,961 / yr |
| 🇫🇷 FR Taxable | 30% | 1444.79% | 1441.99% | $144,479 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CUTR pays quarterly — 4 times per year. Next ex-div: TBD.
How CUTR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CUTR sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2025-02-13 | 623 | $0.42 | $261.00 | ||
| F-InKind | 2025-02-07 | 4,620 | $0.44 | $2.0K | ||
| F-InKind | 2025-02-01 | 22 | $0.43 | $9.00 | ||
| A-Award | 2025-01-01 | 101 | $0.39 | $39.00 | ||
| F-InKind | 2025-01-01 | 47 | $0.39 | $18.00 | ||
| F-InKind | 2025-01-01 | 22 | $0.39 | $9.00 | ||
| F-InKind | 2024-12-01 | 20 | $0.44 | $9.00 | ||
| F-InKind | 2024-11-13 | 2,161 | $0.36 | $767.00 | ||
| F-InKind | 2024-11-07 | 3,794 | $0.51 | $1.9K | ||
| F-InKind | 2024-11-01 | 19 | $0.59 | $11.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CUTR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Cutera, Inc. (CUTR) is currently trading at $0.10, 100% below its 52-week high. The current dividend yield is 2063.98% based on an annual payout of $2.00 per share.
Cutera, Inc. (CUTR) is a healthcare stock currently trading at $0.10 with a dividend yield of 2063.98%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →